mRNA expression fold changes in DEGs of breast tumors with high AGR2 compared to those with low AGR2 were consistent with prior findings highlighting the roles of intracellular and extracellular AGR2 in tumorigenesis pathways mediated by estrogen signaling and Insulin Growth Factor 1 (IGF-1) [38]. The gene discussed is AGR2; the disease is breast neoplasm.